The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets
Open accessAbstract
Background: Altered networks of gene regulation underlie many complex conditions, including cancer. Inferring gene regulatory networks from high-throughput microarray expression data is a fundamental but challenging task in computational systems biology and its translation to genomic medicine. Although diverse computational and statistical approaches have been brought to bear on the gene regulatory network inference problem, their relative strengths and disadvantages remain poorly understood, largely because comparative analyses usually consider only small subsets of methods, use only synthetic data, and/or fail to adopt a common measure of inference quality. Methods: We report a comprehensive comparative evaluation of nine state-of-the art gene regulatory network inference methods encompassing the main algorithmic approaches (mutual information, correlation, partial correlation, random forests, support vector machines) using 38 simulated datasets and empirical serous papillary ovarian adenocarcinoma expression-microarray data. We then apply the best-performing method to infer normal and cancer networks. We assess the druggability of the proteins encoded by our predicted target genes using the CancerResource and PharmGKB webtools and databases. Results: We observe large differences in the accuracy with which these methods predict the underlying gene regulatory network depending on features of the data, network size, topology, experiment type, and parameter settings. Applying the best-performing method (the supervised method SIRENE) to the serous papillary ovarian adenocarcinoma dataset, we infer and rank regulatory interactions, some previously reported and others novel. For selected novel interactions we propose testable mechanistic models linking gene regulation to cancer. Using network analysis and visualization, we uncover cross-regulation of angiogenesis-specific genes through three key transcription factors in normal and cancer conditions. Druggabilty analysis of proteins encoded by the 10 highest-confidence target genes, and by 15 genes with differential regulation in normal and cancer conditions, reveals 75% to be potential drug targets. Conclusions: Our study represents a concrete application of gene regulatory network inference to ovarian cancer, demonstrating the complete cycle of computational systems biology research, from genome-scale data analysis via network inference, evaluation of methods, to the generation of novel testable hypotheses, their prioritization for experimental validation, and discovery of potential drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 1×
“Various approaches have been proposed [20,34,35], but since the range and distribution of network weights is method-dependent, a Madhamshettiwar et al.”
MethodNetwork medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 4×
“Reconstructing gene regulatory networks (GRNs) in healthy and diseased tissues is therefore critical to understanding cancer phenotypes and devising effective therapeutics [3].”
BackgroundInfluentialInferring Regulatory Networks from Expression Data Using Tree-Based Methods
Huynh-Thu, V. A., Irrthum, A., Wehenkel, L., & Geurts, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012776 · Cited by 2,131
Modelling and analysis of gene regulatory networks
Karlebach, G., & Shamir, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2503 · Cited by 1,296
Yu, J., Smith, V. A., Wang, P. P., Hartemink, A. J., & Jarvis, E. D. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth448 · Cited by 675 · cited 1×
“Here we select from about 80 published GRNI methods [21-28] one supervised and eight unsupervised methods that together represent a diversity of mathematical formalisms.”
MethodBonneau, R., Reiss, D. J., Shannon, P., Facciotti, M., Hood, L., Baliga, N. S., & Thorsson, V. (2006) · Genome Biology · doi:10.1186/gb-2006-7-5-r36 · Cited by 510
Towards a rigorous assessment of systems biology models: the DREAM3 challenges
Prill, R. J., Marbach, D., Saez-Rodriguez, J., Sorger, P. K., Alexopoulos, L. G., Xue, X., Clarke, N. D., Altan-Bonnet, G., & Stolovitzky, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009202 · Cited by 439
Cited by
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 435
Emmert-Streib, F., Dehmer, M., & Haibe-Kains, B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00038 · Cited by 282
A review on the computational approaches for gene regulatory network construction
Chai, L. E., Loh, S. K., Low, S. T., Mohamad, M. S., Deris, S., & Zakaria, Z. (2014) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2014.02.011 · Cited by 265
Zinati, Y., Takiddeen, A., & Emad, A. (2023) · doi:10.1101/2023.07.25.550225 · Cited by 36
Metadata
- Authors
- Madhamshettiwar, P. B., Maetschke, S. R., Davis, M. J., Reverter, A., & Ragan, M. A.
- Venue
- Genome Medicine
- Published
- 2012-05-01
- Volume
- 4
- Issue
- 5
- Pages
- 41-41
- ISSN
- 1756-994X (ISSN-L)
- OpenAlex
- W2153011302
- Cited by
- 158
- References
- 9
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets. https://app.cochat.ai/papers/10.1186/gm340
- The paper
- Madhamshettiwar, P. B., Maetschke, S. R., Davis, M. J., Reverter, A., & Ragan, M. A. (2012). Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets. Genome Medicine. https://doi.org/10.1186/gm340
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.